| Net income | 12.56M |
| Depreciation and amortization | |
| Allowance for doubtful accounts | 17K |
| Value of share-based payment arrangements | 601K |
| Amortization of deferred finance costs | |
| Deferred tax benefit | 1.58M |
| Trade accounts receivable | -4.83M |
| Inventories | -4.69M |
| Prepaid and other assets | 741K |
| Accounts payable and accrued expenses | -2.76M |
| Cash provided (used) by operating activities | |
| Additions to patents | 0 |
| Additions to property, plant, and equipment | -877K |
| Cash used by investing activities | |
| Proceeds from issuance of common stock - net | 2.63M |
| Purchase of common stock equivalents | |
| Proceeds from short-term debt - net | -5.21M |
| Proceeds from issuance of long-term debt | 27K |
| Repayment of long-term debt | -264K |
| Cash provided (used) by financing activities | |
| Increase (decrease) in cash and cash equivalents | 2.72M |
| Cash and cash equivalents at beginning of period | 1.26M |
| Cash and cash equivalents at end of period | 3.98M |
| Cash paid during period for interest | 806K |
| Cash paid for income taxes | |